Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Drug Discovery Sector?

The expansion of the drug discovery market has been rapid in the past few years. This growth is set to continue with an increase from $110.26 billion in 2024 to $124.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.6%. Factors driving the growth during the historical period include advancements in the fields of genomics and proteomics, a rising incidence of chronic diseases, and the rise of the biopharmaceutical sector.

The market size for drug discovery is projected to witness a swift expansion in the upcoming years. The market is set to reach $217.01 billion in 2029, growing at a compound annual growth rate of 15.0%. This growth during the forecasted period can be credited to the adoption of precision medicine, the emphasis on rare diseases, and the spread of personalized therapies. Main trends during the forecast period include the participation in cooperative drug discovery models, concentration on rare diseases and orphan drugs, the incorporation of multi-omics data, the quick adoption of organoids, and 3D cell culture models along with progress in virtual screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Forces Are Driving The Growth Of The Drug Discovery Market?

The anticipated escalation in healthcare costs is likely to drive the growth of the drug discovery market. Globally, a substantial portion of countries’ GDP is allocated towards healthcare expenditures, encompassing hospital care, physician and clinical services, dental facilities, residential health and personal care, home healthcare, nursing homes, continued care retirement communities, prescription medications, among others. The drug discovery sector constitutes a major chunk of health expenses as it is pivotal for disease treatment and lifespan extension. The demand for new medications to tackle emerging diseases is on the rise. An example of this was seen in October 2024 when, according to the Centers for Medicare and Medicaid Services, a US federal agency, the national health spending rose by 4.1% to $4.5 trillion in 2022, equating to $13,493 per individual. Between 2023 and 2032, the average growth of national health expenditure, projected to be 5.6%, is expected to surpass the average GDP growth of 4.3%. This would increase the healthcare spending portion of the GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Hence, the upsurge in healthcare expenditure is propelling the expansion of the drug discovery market.

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What Upcoming Trends Are Expected To Impact The Drug Discovery Market Globally?

Progress in technology is a major trend shaping the drug discovery industry. Firms in this field are incorporating new tech tools, such as AI and imaging technology, to decrease the time it takes to discover drugs. Imaging technology offers a non-invasive means for visualizing, documenting, and quantifying biological responses within organisms as they interact with drugs. These techniques, leveraging either the probes or the tissue itself, are essential for disease understanding and the development of new remedies. For instance, Google Cloud launched two AI-based tools in May 2023, the Target and Lead Identification Suite and the Multiomics Suite, to expedite drug discovery and precision medicine. These tools are envisioned to support biotech and pharmaceutical companies in their drug discovery and precision medicine efforts. The Target and Lead Identification Suite helps in defining the function of proteins and amino acids, while the Multiomics Suite quickens the discovery and analysis of genomic data, thus assisting in the creation of precise treatments.

Which Companies Currently Dominate The Competitive Landscape In The Drug Discovery Industry?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Geographic Regions Are Driving Demand In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model